West Pharmaceutical Services, Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Total Cash from Operations: $356.9M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $104.7M | 29.3% |
| Dividends Paid | $42.1M | 11.8% |
| Stock Repurchases | $70.8M | 19.8% |
| Working Capital | $37.8M | 10.6% |
| Net Cash Flow | $101.5M | 28.4% |